US12403090 — Oral film compositions and dosage forms having precise active dissolution profiles
Method of Use · Assigned to Aquestive Therapeutics Inc · Expires 2039-09-05 · 13y remaining
What this patent protects
This patent protects oral film compositions for delivering active ingredients, including clobazam, for treating conditions such as epilepsy and seizures.
USPTO Abstract
An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.
Drugs covered by this patent
- Onfi (CLOBAZAM) · Lundbeck Pharms Llc
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-724 |
— | Onfi |
U-724 |
— | Onfi |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.